Signaturefd, LLC Cue Biopharma, Inc. Transaction History

Signaturefd, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$10.86 - $17.85 $923 - $1,517	-85 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$10.06 - $15.3 $855 - $1,300	85 New	85 $1,000
Q3 2020 Nov 03, 2020	SELL	$15.05 - $23.54 $1,128 - $1,765	-75 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$12.7 - $30.73 $952 - $2,304	75 New	75 $2,000

12.1M

25.6K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $52.7M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.